Living with pulmonary arterial hypertension is challenging, but the chore of treating the rare heart disease may change following promising clinical trial data to be published in the Dec. 24 issue of the New England Journal ...
Dec 23, 2015
0
51
A protein that targets the effects of a faulty gene could offer the first treatment targeting the major genetic cause of Pulmonary Arterial Hypertension (PAH), according to research funded by the British Heart Foundation ...
Jun 16, 2015
0
126
New research has found that a variant of a drug used to treat pulmonary arterial hypertension prompts weight loss in obese mice. Among mice fed a high-fat diet, those who did not get the medication became obese while medicated ...
May 28, 2015
0
99
Pulmonary hypertension is characterised by uncontrolled division of cells in the blood vessel walls. As a result, the vessel walls become increasingly thick.
Oct 27, 2014
0
0
(Medical Xpress)—Impairment of a key signaling cascade in the pulmonary blood vessels plays an important role in pulmonary arterial hypertension, a Yale study has found. The study appears in the advance online publication ...
Dec 27, 2012
0
0
In 2023, The European Alliance of Associations for Rheumatology(EULAR) updated its recommendations for the treatment of systemic sclerosis (SSc), with many new inclusions around manifestations such as skin fibrosis and interstitial ...
Jun 14, 2024
0
1
Pericytes, the multifunctional cells that work within the walls of capillaries, have been a subject of focus in the study of vascular development, cerebral blood flow, cancer, and neurodevelopment diseases.
Jun 12, 2024
0
0
Lung cancer can advance quickly. Once a person starts treatment, it is vital to know whether that treatment is working or if the patient should be switched to a different treatment. New advanced imaging technology at UC Davis ...
Jun 10, 2024
0
0
Since the dawn of the jet age, travelers have been warned about the risks of dangerous blood clots while flying. In recent years, those warnings have often been accompanied by advice to wear compression socks.
Jun 6, 2024
0
5
The U.S. Food and Drug Administration has approved Winrevair (sotatercept-csrk) as an injectable treatment for pulmonary arterial hypertension (PAH) in adults.
Mar 29, 2024
0
1
